Renerve (ASX:RNV)
ASX announcement history & article coverage
Transparent by design.
Announcments by Renerve (ASX:RNV) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notice of Annual General Meeting/Proxy Form
ReNerve - Corporate Governance Statement
ReNerve - Appendix 4G
ReNerve - Full Year Results
ReNerve Reports Record FY26 Sales Growth and Expands Global Market Access
ReNerve - 2026 Annual Report
ReNerve reports 88% revenue growth, expands Asia-Pacific approvals, advances nerve repair pipeline, and secures $5 million funding facility
ReNerve - Appendix 4E
ReNerve Limited reports increased loss and lower net tangible assets for FY2026
Cleansing Notice
Application for quotation of securities - RNV
Proposed issue of securities - RNV
Quarterly Investor Presentation
ReNerve reports strong revenue growth and advances nerve repair product pipeline with global expansion
Quarterly Investor Webinar
ReNerve Secures Marketing Approval in India
ReNerve Secures Indian Marketing Approval for NervAlign® Nerve Cuff
ReNerve Secures Marketing Approval in the Philippines
ReNerve gains marketing approval for NervAlign® Nerve Cuff in the Philippines, expanding Asia-Pacific footprint
Change of Director's Interest Notice - J Chick
Q4 FY26 Activities Report and Appendix 4C
ReNerve reports record sales, Asia-Pacific expansion, and $5M funding facility
Notification regarding unquoted securities - RNV
Proposed issue of securities - RNV
ReNerve Secures up to A$5 Million Funding Facility
ReNerve secures up to A$5 million convertible note facility to fund growth and commercialisation
ReNerve Secures Marketing Approval in Indonesia
ReNerve gains marketing approval for NervAlign® Nerve Cuff in Indonesia, expanding Asia-Pacific footprint
Notification of cessation of securities - RNV
Clarification of Key Terms STC Distribution Agreement
ReNerve appoints J4 as second Empliq manufacturing partner
ReNerve appoints J4 as second Empliq manufacturing partner to scale production amid rising demand
ReNerve appoints distribution partner for Malaysian Market
ReNerve appoints UG Medical as Malaysian distributor for NervAlign products
